Compounds > nitroxyl

nitroxyl and nitroglycerin

nitroxyl has been researched along with nitroglycerin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Galagan, ME; Kalvin'sh, IIa; Kubrina, LN; Kuzmanis, IaA; Mordvintsev, PI; Vanin, AF; Vedernikov, IuI1
Favaloro, JL; Irvine, JC; Kemp-Harper, BK; Widdop, RE1
Irvine, JC; Kemp-Harper, BK; Widdop, RE1
Andrews, KL; Chin-Dusting, JP; Farry, J; Jefferis, AM; Kemp-Harper, BK; Lumsden, NG1

Other Studies

4 other study(ies) available for nitroxyl and nitroglycerin

ArticleYear
[Angeli salt as a producer of nitrogen oxide in animal tissues].
    Biokhimiia (Moscow, Russia), 1990, Volume: 55, Issue:8

    Topics: Animals; Blood Pressure; Electron Spin Resonance Spectroscopy; Free Radicals; Hemoglobins; Male; Mice; Nitric Oxide; Nitrites; Nitrogen Oxides; Nitroglycerin; Nitroprusside; Rats

1990
Nitroxyl anion donor, Angeli's salt, does not develop tolerance in rat isolated aortae.
    Hypertension (Dallas, Tex. : 1979), 2007, Volume: 49, Issue:4

    Topics: Animals; Aorta, Thoracic; Benzoates; Cyclic GMP-Dependent Protein Kinases; Cysteine; Drug Tolerance; Enzyme Inhibitors; Free Radical Scavengers; Hydrazines; Imidazoles; In Vitro Techniques; Male; Nitric Oxide; Nitric Oxide Donors; Nitrites; Nitrogen Oxides; Nitroglycerin; Oxadiazoles; Quinoxalines; Rats; Rats, Inbred WKY; Time Factors; Vasodilation

2007
Chronic administration of the HNO donor Angeli's salt does not lead to tolerance, cross-tolerance, or endothelial dysfunction: comparison with GTN and DEA/NO.
    Antioxidants & redox signaling, 2011, May-01, Volume: 14, Issue:9

    Topics: Acetylcholine; Animals; Aorta; Cyclic GMP; Diethylamines; In Vitro Techniques; Male; Nitric Oxide Donors; Nitrites; Nitrogen Oxides; Nitroglycerin; Rats

2011
Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance.
    Clinical science (London, England : 1979), 2015, Volume: 129, Issue:2

    Topics: Cyclic GMP; Dose-Response Relationship, Drug; Drug Tolerance; Enzyme Inhibitors; Guanylate Cyclase; Humans; In Vitro Techniques; Nitric Oxide Donors; Nitrites; Nitrogen Oxides; Nitroglycerin; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Radial Artery; Receptors, Cytoplasmic and Nuclear; Saphenous Vein; Soluble Guanylyl Cyclase; Vasodilation; Vasodilator Agents

2015